King's College London

Research portal

Research Outputs

  1. 2017
  2. Are nutraceuticals the modern panacea? From myth to science

    Minuz, P., Velo, G., Violi, F. & Ferro, A., 1 Jan 2017, In : British Journal of Clinical Pharmacology. 83, 1, p. 5-7 3 p.

    Research output: Contribution to journalEditorial

  3. 2016
  4. 21st Century Research in Child Neurology: Development Disorders of the immature brain

    Gressens, P. & Ferriero, D. M., Aug 2016, In : Neurobiology of Disease. 92, Part A, p. 1-2 2 p.

    Research output: Contribution to journalEditorial

  5. Organised crime against the academic peer review system

    Cohen, A., Pattanaik, S., Kumar, P., Bies, R. R., de Boer, A., Ferro, A., Gilchrist, A., Isbister, G. K., Ross, S. & Webb, A. J., Jun 2016, In : British Journal of Clinical Pharmacology. 81, 6, p. 1012-7 6 p.

    Research output: Contribution to journalEditorial

  6. Newer antiplatelet agents in acute coronary syndrome: Does prescribing outpace evidence?

    Ferro, A., 7 Jan 2016, In : BMJ (Clinical research ed.). 352, h7025.

    Research output: Contribution to journalEditorial

  7. 2015
  8. Adverse drug reactions

    Rieder, M. & Ferro, A., 1 Oct 2015, In : British Journal of Clinical Pharmacology. 80, 4, p. 613-614 2 p.

    Research output: Contribution to journalEditorial

  9. 2012
  10. Integrated mechanism reviews

    Dammann, O. & Gressens, P., May 2012, In : Pediatric Research. 71, 5, p. 530-531 2 p., N/A.

    Research output: Contribution to journalEditorial

  11. Untitled - Editors' report

    Somogyi, A. A., Lewis, L. D., Cohen, A. F., Ferro, A., Loke, Y. K. & Ritter, J. M., Feb 2012, In : British Journal of Clinical Pharmacology. 73, 2, p. 159 - 160 2 p.

    Research output: Contribution to journalEditorial

  12. Editors' pick 2011

    Somogyi, A., Loke, Y. K., Ferro, A., Lewis, L. D., Cohen, A. F. & Ritter, J. M., Jan 2012, In : British Journal of Clinical Pharmacology. 73, 1, p. 4 - 8 5 p.

    Research output: Contribution to journalEditorial

  13. 2011
  14. "European Panel On Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary

    Mikhailidis, D. P., Elisaf, M., Rizzo, M., Berneis, K., Griffin, B., Zambon, A., Athyros, V., de Graaf, J., Maerz, W., Parhofer, K. G., Rini, G. B., Spinas, G. A., Tomkin, G. H., Tselepis, A. D., Wierzbicki, A. S., Winkler, K., Florentin, M. & Liberopoulos, E., Sep 2011, In : Current Vascular Pharmacology. 9, 5, p. 531 - 532 2 p.

    Research output: Contribution to journalEditorial

  15. Neonatal encephalopathy or hypoxic-ischemic encephalopathy? Appropriate terminology matters

    Dammann, O., Ferriero, D. & Gressens, P., Jul 2011, In : Pediatric Research. 70, 1, p. 1-2 2 p., N/A.

    Research output: Contribution to journalEditorial

  16. THERAPEUTICS Oral antiplatelet agents clopidogrel and prasugrel for the prevention of cardiovascular events

    Passacquale, G. & Ferro, A., 25 Jun 2011, In : BMJ. 342, 7812, d3488.

    Research output: Contribution to journalEditorial

  17. Editors' pick 2010

    Loke, Y. K., Ferro, A., Lewis, L. D., Cohen, A. F., Somogyi, A. & Ritter, J. M., Jan 2011, In : British Journal of Clinical Pharmacology. 71, 1, p. 3 - 6 4 p.

    Research output: Contribution to journalEditorial

  18. Untitled

    Cohen, A. F., Loke, Y. K., Ferro, A., Lewis, L. D., Somogy, A. & Ritter, J. M., Jan 2011, In : British Journal of Clinical Pharmacology. 71, 1, p. 1 - 2 2 p.

    Research output: Contribution to journalEditorial

  19. 2010
  20. Clinical pharmacology: a declaration of intent

    Somogyi, A., Loke, Y. K., Ferro, A., Lewis, L. D., Cohen, A. F. & Ritter, J. M., Jul 2010, In : British Journal of Clinical Pharmacology. 70, 1, p. 1 - 2 2 p.

    Research output: Contribution to journalEditorial

  21. Editors' pick 2009

    Somogyi, A., Loke, Y. K., Ferro, A., Lewis, L. D., Cohen, A. F. & Ritter, J. M., 2010, In : British Journal of Clinical Pharmacology. 69, 2, p. 107 - 110 4 p.

    Research output: Contribution to journalEditorial

  22. 2006
  23. Erectile dysfunction in diabetes: NO role for the endothelium?

    Ferro, A., Oct 2006, In : International Journal of Clinical Practice. 60, 10, p. 1154 - 1155 2 p., -.

    Research output: Contribution to journalEditorial

  24. beta-adrenoceptors and potassium channels

    Ferro, A., 2006, In : Naunyn-Schmiedeberg's Archives of Pharmacology. 373, 3, p. 183 - 185 3 p.

    Research output: Contribution to journalEditorial

  25. 2004
  26. Genetics and molecular biology: Genetic epidemiology

    Wierzbicki, A. S., Dec 2004, In : Current Opinion in Lipidology. 15, 6, p. 699 - 701 3 p.

    Research output: Contribution to journalEditorial

  27. Chemical pathology and the new contract for GPs

    Twomey, P. J., Wierzbicki, A. S. & Reynolds, T. M., Oct 2004, In : Journal of Clinical Pathology. 57, 10, p. 1022 - 1024 3 p.

    Research output: Contribution to journalEditorial

  28. The casino of life

    Twomey, P. J., Reynolds, T. M. & Wierzbicki, A. S., Mar 2004, In : Journal of Clinical Pathology. 57, 3, p. 243 - 244 2 p.

    Research output: Contribution to journalEditorial

  29. Raising high-density lipoprotein

    Wierzbicki, A. S., 2004, In : International Journal of Clinical Practice. 58, 9, p. 817 - 819 3 p.

    Research output: Contribution to journalEditorial

  30. 2003
  31. Ezetimibe: a new addition to lipid-lowering therapy

    Wierzbicki, A. S., Oct 2003, In : International Journal of Clinical Practice. 57, 8, p. 653 - 655 3 p.

    Research output: Contribution to journalEditorial

  32. Imidazole derivatives as cholesterol-lowering agents

    Wierzbicki, A. S., Aug 2003, In : International Journal of Cardiology. 90, 2-3, p. 145 - 146 2 p.

    Research output: Contribution to journalEditorial

  33. Treatment-to-target for lipids in primary care

    Wierzbicki, A. S., Jul 2003, In : International Journal of Clinical Practice. 57, 6, p. 459 - 460 2 p.

    Research output: Contribution to journalEditorial

  34. Aggressive lipid-lowering therapy in high-risk groups: warranted or excessive?

    Wierzbicki, A. S., May 2003, In : International Journal of Clinical Practice. 57, 4, p. 256 - 257 2 p.

    Research output: Contribution to journalEditorial

  35. Renal dopamine receptors and hypertension

    Ferro, A., 2003, In : Journal of Hypertension. 21, 1, p. 37 - 38 2 p.

    Research output: Contribution to journalEditorial

  36. 2002
  37. Statins and vascular protection: a 'radical' view

    Ferro, A., Mar 2002, In : Journal of Hypertension. 20, 3, p. 359 - 361 3 p.

    Research output: Contribution to journalEditorial

  38. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

    Mikhailidis, D. P. & Wierzbicki, A. S., 2002, In : Current Medical Research and Opinion. 18, 4, p. 215 - 219 5 p.

    Research output: Contribution to journalEditorial

  39. 2001
  40. Is a statin a statin?

    Wierzbicki, A. S., 2001, In : International Journal of Clinical Practice. 55, 2, p. 79 - 80 2 p.

    Research output: Contribution to journalEditorial

  41. Synthetic statins: More data on newer lipid-lowering agents

    Wierzbicki, A. S., 2001, In : Current Medical Research and Opinion. 17, 1, p. 74 - 77 4 p.

    Research output: Contribution to journalEditorial

  42. 2000
  43. Does diet have a role in the treatment of hyperlipidaemia?

    Wierzbicki, A. S., 2000, In : International Journal of Clinical Practice. 54, 2, p. 72 - 73 2 p.

    Research output: Contribution to journalEditorial

Export:RIS BibTex Word PDF - will at most contain 500 items

Refine results Clear filters

Language

Language

Publication year

Full text

Full text

Meeting and poster abstracts

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454